AI-enabled drug discovery cuts discovery time by 15-80%, McKinsey research finds
menhguin · x · 2026-09-23
Dr. Samuel Hume highlights new McKinsey research showing early signs that AI is genuinely speeding up drug discovery: the featured candidates were all AI-enabled, with discovery time reduced by roughly 15-80%. The author calls the trend 'incredibly bullish' for AI in biopharma R&D.
More from Research
- Genome LM Minerva finds reverse transcriptase systems encode diverse structured ncRNAs — BrianHie · 2026-09-23
- q-Neurons: stochastic Jackson-derivative activations consistently beat standard ones — FrnkNlsn · 2026-09-23
- OpenAI said to launch journal with multi-agent AI reviews, threatening ML conferences — kfountou · 2026-09-23
- Yale PhD student open-sources his paper figure scripts, packaged as a Skill for Claude Code and Cursor — burny_tech · 2026-09-23
- AI models now match superforecasters on ForecastBench; rematch set for October — burny_tech · 2026-09-23
- Dev uses Opus 5.5 with Lean to formally verify Claude Agent SDK, yielding 16 bug-fix PRs — bcherny · 2026-09-23